MRD testing showed weak trial-level correlation with progression-free survival in BTK inhibitor and venetoclax-based CLL studies.

In this study, researchers investigated the potential impacts of “shared decision-making” replacing universal HBV birth-dose vaccination on neonatal and later chronic HBV infections.

The Turkish version of the RCAC Scale demonstrated cultural relevance, validity, and reliability in assessing fertility concerns of women with cancer in this population.

Survey study compared facilitators and barriers to lymphoma clinical trial participation for non-Hispanic White, Hispanic, and African American and male and female patients.

Investigators constructed weighted methylation risk scores to pinpoint specific risk factors associated with early-onset CRC versus late-onset CRC.

Men diagnosed at screening aged 50 years projected to have 16 percent chance that cancer would not have been detected within 15 years.

Researchers sought to determine whether combination bortezomib and vorinostat into a multi-agent induction chemotherapy would be safe and effective in infant ALL.

Investigators compared the efficacy of a dyadic yoga intervention relative to an education/support program targeting patient functional capacity and patient and caregiver quality-of-life outcomes.

Recommendations say clinicians should use biennial mammography for breast cancer screening in asymptomatic, average-risk women aged 50 to 74 years.

Researchers studied the prevalence of proliferative endometrial disorders in women with adenomyosis and evaluated the association between adenomyosis and each lesion type.

The approval is supported by bioequivalence data assessing the once-daily extended-release formulation to twice-daily immediate-release ruxolitinib in healthy participants.

This randomized clinical trial compared quality of life measures achieved with a mhealth intervention with those of standard care in patients undergoing HSCT.